Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals Inc Cl A (NQ: RXRX )

9.027 -0.333 (-3.56%)
Streaming Delayed Price Updated: 12:21 PM EDT, May 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals Inc Cl A

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Gold Rises Over 1%; Recursion Pharmaceuticals Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Wednesday. The Dow traded up 0.33% to 34,374.56 while the NASDAQ rose 1.21% to 13,926.89. The S&P 500,... 
Via Benzinga
Recursion Pharmaceuticals (NASDAQ: RXRX) Forms Powerful Partnership with NVIDIA (NASDAQ: NVDA)
A $50 Million Investment to Boost AI Capabilities in Drug Discovery Recursion Pharmaceuticals (NASDAQ: RXRX), a trailblazer in TechBio that 
Via Spotlight Growth
Topics Artificial Intelligence
Exposures Artificial Intelligence
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Stocks Extend Rally On Cooler-Than-Expected CPI Reading
The S&P 500 Index and Nasdaq Composite sport solid midday leads, as investors hope the data may push the Federal Reserve away from more interest rate hikes. 
Via Talk Markets
Why Shares of Recursion Pharmaceuticals Are Skyrocketing Wednesday
The company just received a $50 million investment from Nvidia. 
Via The Motley Fool
Expert Ratings for Recursion Pharmaceuticals
Via Benzinga
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market. 
Via Benzinga
Why Recursion Pharmaceuticals Stock is Skyrocketing Today?
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares are trading higher after the company announced a $50 million investment by NVIDIA Corporation (NASDAQ: NVDA), executed as a private  
Via Benzinga
S&P 500 Gains 1%; US Crude Oil Inventories Increase More Than Projected
U.S. stocks traded higher midway through trading, with the S&P 500 gaining 1% on Wednesday. The Dow traded up 0.84% to 34,550.13 while the NASDAQ rose 1.32% to 13,941.87. The S&P 500, also rose,... 
Via Benzinga
Recursion Catapults 70% On Nvidia Investment For AI In Drug Development
Nvidia is hoping to help this company accelerate its efforts in AI-related drug development. 
Via Investor's Business Daily
InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Nasdaq Rises Over 1%; US Inflation Rate Falls In June
U.S. stocks traded higher this morning, with the Nasdaq Composite surging over 1% on Wednesday. Following the market opening Wednesday, the Dow traded up 0.78% to 34,527.32 while the NASDAQ rose 1.18%... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
Companies to collaborate on software for biotech and pharmaceutical companies to create improved patient treatments faster 
From Recursion Pharmaceuticals
Via GlobeNewswire
Nanobiotix, NanoString Technologies And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom
AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider. 
Via InvestorPlace
Cash In on the Longevity Boom: 3 Biotech Stocks to Buy Now
With longevity back in the news, many investors are wondering which biotech stocks to buy to best cash in on the growing trend. 
Via InvestorPlace
Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled
Recursion's small molecule is the first therapeutic candidate to be advanced to an industry-sponsored Phase 2 clinical trial for cerebral cavernous malformation (CCM). CCM is a devastating... 
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion Pharmaceuticals Is Going Big on AI. Here's Why It Could Be Worth Buying
It's competing in a soon-to-be hotly contested space. 
Via The Motley Fool
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. 
Via Benzinga
Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities
From Recursion Pharmaceuticals
Via GlobeNewswire
Recursion to Participate in Upcoming Investor Conferences
From Recursion Pharmaceuticals
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.